Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer

Summary of combinatorial effects of ISC-4 with approved antitumor agents. (2013) Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer.

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 11
Main Authors Allen, Joshua E., Gallant, Jean-Nicolas, Dicker, David T., Amin, Shantu, Irby, Rosalyn B., Sharma, Arun K., El-Deiry, Wafik S.
Format Journal Article
LanguageEnglish
Published San Francisco Public Library of Science 07.11.2013
Public Library of Science (PLoS)
Subjects
AKT protein
Colon
Colon cancer
Colorectal cancer
Online AccessGet full text

Cover

More Information
Summary:Summary of combinatorial effects of ISC-4 with approved antitumor agents. (2013) Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer.
Bibliography:correction
ISSN:1932-6203
1932-6203
DOI:10.1371/annotation/aaa12360-0c90-42c3-bc43-d00022b68b81